[go: up one dir, main page]

UY26465A1 - Compuestos y composiciones antipicornavirales, sus usos farmacéuticos, y materiales para su sintesis. - Google Patents

Compuestos y composiciones antipicornavirales, sus usos farmacéuticos, y materiales para su sintesis.

Info

Publication number
UY26465A1
UY26465A1 UY26465A UY26465A UY26465A1 UY 26465 A1 UY26465 A1 UY 26465A1 UY 26465 A UY26465 A UY 26465A UY 26465 A UY26465 A UY 26465A UY 26465 A1 UY26465 A1 UY 26465A1
Authority
UY
Uruguay
Prior art keywords
compounds
synthesis
compositions
materials
pharmaceutical uses
Prior art date
Application number
UY26465A
Other languages
English (en)
Inventor
Peter S Dragovich
Thomas J Prins
Ru Zhou
Theodore O Johnson Jr
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Publication of UY26465A1 publication Critical patent/UY26465A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se revelan los compuestos de la fórmula: donde las variables de la fórmula son como se define aquí, que ventajosamente inhiben o bloquean la actividad biológica de la proteasa picornaviral 3C. Estos compuestos, así como las composiciones farmacéuticas que contienen estos compuestos, son útiles para el tratamiento de pacientes o huéspedes infectados con uno o más picornaviruses como las proteasas rinovirus 3C. También se describen métodos intermediarios y sintéticos para preparar estos compuestos.
UY26465A 1999-12-03 2000-12-01 Compuestos y composiciones antipicornavirales, sus usos farmacéuticos, y materiales para su sintesis. UY26465A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16898699P 1999-12-03 1999-12-03
US19205200P 2000-03-24 2000-03-24

Publications (1)

Publication Number Publication Date
UY26465A1 true UY26465A1 (es) 2001-06-29

Family

ID=26864652

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26465A UY26465A1 (es) 1999-12-03 2000-12-01 Compuestos y composiciones antipicornavirales, sus usos farmacéuticos, y materiales para su sintesis.

Country Status (31)

Country Link
US (1) US6514997B2 (es)
EP (1) EP1252145A1 (es)
JP (1) JP2003515591A (es)
KR (1) KR20020058076A (es)
CN (1) CN1402710A (es)
AP (1) AP2002002510A0 (es)
AR (1) AR030540A1 (es)
AU (1) AU777943B2 (es)
BG (1) BG106754A (es)
BR (1) BR0016742A (es)
CA (1) CA2392504A1 (es)
CO (1) CO5261566A1 (es)
CZ (1) CZ20021906A3 (es)
DO (1) DOP2000000108A (es)
EA (1) EA200200625A1 (es)
EE (1) EE200200281A (es)
HK (1) HK1052933A1 (es)
HU (1) HUP0204006A3 (es)
IL (1) IL149427A0 (es)
IS (1) IS6378A (es)
MX (1) MXPA02005124A (es)
NO (1) NO20022589L (es)
NZ (1) NZ518934A (es)
OA (1) OA12101A (es)
PA (1) PA8507801A1 (es)
PE (1) PE20020157A1 (es)
PL (1) PL356062A1 (es)
SK (1) SK7602002A3 (es)
UY (1) UY26465A1 (es)
WO (1) WO2001040189A1 (es)
YU (1) YU40002A (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA003856B1 (ru) 1998-04-30 2003-10-30 Агурон Фармасьютикалз, Инк. Антипикорнавирусные композиции, их получение и применение
PA8515201A1 (es) 2000-04-14 2002-10-24 Agouron Pharma Compuestos y composiciones antipicornavirales; sus usos farmaceuticos y los materiales para su sintesis
JP2004503533A (ja) * 2000-06-14 2004-02-05 アグロン・ファーマシュウティカルズ・インコーポレーテッド 抗ピコルナウイルス化合物及び組成物、その医薬的使用、並びにその合成のための物質
ATE438624T1 (de) * 2000-12-28 2009-08-15 Shionogi & Co 2-pyridonderivate mit affinität für den cannabinoid-typ-2-rezeptor
EP1523483A4 (en) 2002-06-26 2006-03-08 Bristol Myers Squibb Co AMINO-BICYCLIC PYRAZINONE AND PYRIDINONE FOR INHIBITING THE COOKING OF SERIN PROTEASE
EP1606019A1 (en) * 2003-03-07 2005-12-21 The University Court of The University of Aberdeen Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders
WO2004093860A1 (en) * 2003-04-21 2004-11-04 Pfizer Inc. Inhibitors of sars related coronavirus proteinase
US20040235952A1 (en) * 2003-05-05 2004-11-25 Agouron Pharmaceuticals, Inc. Inhibitors of severe acute respiratory syndrome (SARS) 3C-like proteinase
CA2550515A1 (en) * 2003-12-31 2005-07-21 Taigen Biotechnology Protease inhibitors
US7462594B2 (en) * 2003-12-31 2008-12-09 Taigen Biotechnology Co., Ltd. Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases
US7087622B2 (en) 2004-05-07 2006-08-08 Janssen Pharmaceutica N.V. Pyridone compounds as inhibitors of bacterial type III protein secreation systems
GB0702862D0 (en) * 2007-02-14 2007-03-28 Univ Aberdeen Therapeutic compounds
KR100891699B1 (ko) 2007-04-10 2009-04-03 광주과학기술원 7-아미노-4-((ｓ)-3-(4-플루오로페닐)-2-((r)-3-메틸-2-(5-메틸이소옥사졸-3-카복사미도)부탄아미도)프로판아미도)-7-옥소-2-헵테노에이트 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 및 치료용 약학적 조성물
EP2320891B1 (en) * 2008-08-29 2013-10-09 Treventis Corporation Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system
KR101385855B1 (ko) * 2012-10-16 2014-04-22 이동익 카뎁신 검출용 다이아로마틱 아미노산 기질
EP3455205A4 (en) * 2016-05-13 2020-01-01 Emory University Peptidomimetics for the treatment of norovirus infection
US11124497B1 (en) 2020-04-17 2021-09-21 Pardes Biosciences, Inc. Inhibitors of cysteine proteases and methods of use thereof
JP2023522990A (ja) * 2020-04-23 2023-06-01 パーデュー・リサーチ・ファウンデーション Ｓａｒｓの治療のための化合物
US11174231B1 (en) 2020-06-09 2021-11-16 Pardes Biosciences, Inc. Inhibitors of cysteine proteases and methods of use thereof
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652676A (en) 1985-05-06 1987-03-24 General Foods Corporation L-aminodicarboxylic acid alkenes
US5374623A (en) 1992-08-20 1994-12-20 Prototek, Inc. Cysteine protease inhibitors effective for in vivo use
US5514778A (en) 1993-07-01 1996-05-07 Eli Lilly And Company Anti-picornaviral agents
US5486623A (en) 1993-12-08 1996-01-23 Prototek, Inc. Cysteine protease inhibitors containing heterocyclic leaving groups
IL112759A0 (en) 1994-02-25 1995-05-26 Khepri Pharmaceuticals Inc Novel cysteine protease inhibitors
IT1269511B (it) 1994-05-17 1997-04-01 Univ Degli Studi Milano Derivati di acidi ammino-solfonici , loro impiego nella sintesi di pseudopeptidi e procedimento per la loro preparazione
US5498616A (en) 1994-11-04 1996-03-12 Cephalon, Inc. Cysteine protease and serine protease inhibitors
WO1996030395A2 (en) 1995-03-31 1996-10-03 Takeda Chemical Industries, Ltd. Cysteine protease inhibitor
IT1281031B1 (it) 1995-11-17 1998-02-11 Carlo Chiaves Struttura prefabbricata per la realizzazione di opere costruite a cielo aperto, particolarmente per cavalcavia autostradali,
DE69733137T2 (de) 1996-05-14 2006-03-02 Agouron Pharmaceuticals, Inc., San Diego Inhibitoren von picornavirus 3c protease und verfahren zur herstellung und verwendung
US5856530A (en) 1996-05-14 1999-01-05 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and methods for their use and preparation
WO1997049668A1 (en) 1996-06-13 1997-12-31 Smithkline Beecham Corporation Inhibitiors of cysteine protease
US6020371A (en) 1997-03-28 2000-02-01 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds compositions containing them and methods for their use
PT975588E (pt) * 1997-03-28 2004-02-27 Agouron Pharma Compostos antipicornavirais, composicoes que os contem e metodos para a sua utilizacao
US6331554B1 (en) 1997-03-28 2001-12-18 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds, compositions containing them, and methods for their use
US5962487A (en) 1997-12-16 1999-10-05 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and methods for their use and preparation
EA003856B1 (ru) * 1998-04-30 2003-10-30 Агурон Фармасьютикалз, Инк. Антипикорнавирусные композиции, их получение и применение
US6369226B1 (en) 1999-06-21 2002-04-09 Agouron Pharmaceuticals, Inc. Substituted benzamide inhibitors of rhinovirus 3C protease
DE60014670T2 (de) 1999-08-04 2006-03-09 Agouron Pharmaceuticals, Inc., San Diego Antipicornavirale verbindungen und zusammensetzungen, ihre pharmazeutische verwendung, und materialien für ihre synthese
IL147862A0 (en) 1999-08-24 2002-08-14 Agouron Pharma Process and intermediates for the preparation os isoxazolecaroxamides and analogues
PE20010517A1 (es) 1999-08-24 2001-05-16 Agouron Pharma Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves

Also Published As

Publication number Publication date
AU777943B2 (en) 2004-11-04
IL149427A0 (en) 2002-11-10
HUP0204006A3 (en) 2004-11-29
DOP2000000108A (es) 2003-03-15
WO2001040189A1 (en) 2001-06-07
JP2003515591A (ja) 2003-05-07
PE20020157A1 (es) 2002-02-22
MXPA02005124A (es) 2003-01-28
KR20020058076A (ko) 2002-07-12
BR0016742A (pt) 2002-09-03
NZ518934A (en) 2003-11-28
US6514997B2 (en) 2003-02-04
IS6378A (is) 2002-05-10
EE200200281A (et) 2003-06-16
NO20022589D0 (no) 2002-05-31
EA200200625A1 (ru) 2002-12-26
YU40002A (sh) 2006-01-16
BG106754A (bg) 2003-07-31
HUP0204006A2 (hu) 2003-03-28
CO5261566A1 (es) 2003-03-31
AR030540A1 (es) 2003-08-27
HK1052933A1 (zh) 2003-10-03
PA8507801A1 (es) 2002-08-26
AP2002002510A0 (en) 2002-06-30
EP1252145A1 (en) 2002-10-30
US20010047006A1 (en) 2001-11-29
OA12101A (en) 2006-05-04
PL356062A1 (en) 2004-06-14
AU1809401A (en) 2001-06-12
CN1402710A (zh) 2003-03-12
SK7602002A3 (en) 2003-02-04
NO20022589L (no) 2002-07-31
CZ20021906A3 (cs) 2003-02-12
CA2392504A1 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
UY26465A1 (es) Compuestos y composiciones antipicornavirales, sus usos farmacéuticos, y materiales para su sintesis.
PA8547601A1 (es) Inhibidores de la proteasa del vih, composiciones que los contienen, sus usos farmaceuticos y materiales para su sintesis
DK1206484T3 (da) Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese
DE60107687D1 (de) Cyclpentanoindole, mischungen derartige verbindungen enthaltend und behandlungsmethoden
UY29458A1 (es) Heterociclos sustituidos y usos de los mismos
ATE433447T1 (de) Pyrimiidinverbindungen
YU66000A (sh) Antipikovirusna jedinjenja, njihovo dobijanje i upotreba
PA8429901A1 (es) Compuestos antipicornavirales y metodos para su uso y preparacion
ES2243579T3 (es) Derivados de pirazolopirideno.
UY26666A1 (es) Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
ATE251624T1 (de) Granulatimide-derivate zur behandlung von krebs
SE9901077D0 (sv) Novel use
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
DK0975588T3 (da) Antipicornavirale forbindelser, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse
UY26307A1 (es) Las rutas sintéticas eficientes para la preparación de los inhibidores de la proteasa del rinovirus y los intermedios claves
ES2131015B1 (es) Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas.
ECSP034892A (es) Inhibidores de proteasa vih, composiciones que los contienen, sus usos farmaceuticos y materiales para su síntesis
UY27330A1 (es) Inhibidores de la proteasa del vih, composiciones que los contienen, sus usos farmacéuticos y materiales para su síntesis.
UY27331A1 (es) Inhibidores de la proteasa del vih, composiciones que los contienen, sus usos farmacéuticos y materiales para su síntesis
GT200000206A (es) Compuestos y composiciones antipicornavirales sus usos farmaceuticos y materiales para su sintesis.
BR0111727A (pt) Compostos e composições antipicornavirais, seus usos farmacêuticos, e materiais para a sua sìntese
SV2004001553A (es) Proteasa inhibidora de vih, composiciones que las contienen, sus usos farmaceuticos y materiales para su sintesis
GT200100088A (es) Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis.
ECSP003630A (es) Rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves
ECSP003846A (es) Pirroles sustituidos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130108